Pain, the opioid epidemic, & depression / Jeffrey F. Scherrer & Jane C. Ballantyne.
| Other author | Scherrer, Jeffrey F. |
| Other author | Ballantyne, Jane, 1948- |
| Other author | Oxford University Press. |
| Format | Electronic |
| Publication Info | New York, NY : Oxford University Press, [2024] |
| Description | xvi,183 pages ; 25 cm |
| Supplemental Content | Full text available from Oxford Scholarship Online |
| Subjects |
| Variant title | Pain, the opioid epidemic, and depression |
| Contents | Overview and purpose -- Neurophysiology of pain, depression, and exogenous opioids -- Looking beyond tissue damage : Pain as a homeostatic function -- Prescription opioid use and risk of depression and worsening mental health -- Depression and pain : Bi-directional relationship and changes with psychological treatment -- Other psychiatric disorders, psychosocial factors and pain -- The impact of social and structural determinants on depression, prescription opioid use, opioid misuse, and opioid use disorder -- Opioid taper and complex prescription opioid dependence : The role of depression -- Potential role for buprenorphine in the management of comorbid depression among people with chronic pain and long-term opioid therapy dependence -- Future directions in pain management, implications for depression and mental health. |
| Abstract | "Opioid prescribing rates peaked in the United States in 2012. Although opioid prescribing in the U.S. has moderated somewhat, the peak of prescribing left a legacy of patients struggling with opioid dependence. Worse still, there is little doubt that the prescription opioid epidemic continues to contribute to subsequent waves of the U.S. opioid epidemic involving heroin and later fentanyl. Much attention is currently focused on the 4th wave of the opioid epidemic, characterized by fentanyl and polydrug abuse. However, minimal progress has been made in reducing prescription opioid overdose deaths. Since 2016 the prevalence of annual drug overdoses involving prescription opioids has remained stable, with 15,000 to 17,000 overdose deaths per year attributed to prescription opioids. More than 140 million opioid prescriptions were written in 2020 which is sufficient to provide a prescription to 70% of the adult, U.S. population. Unfortunately, patients with psychiatric disorders who are at risk for poor outcomes, such as opioid misuse, receive more than 50% of these prescriptions. The prescription opioid epidemic continues to disproportionately impact patients with comorbid pain and mental illness"-- Provided by publisher. |
| Bibliography note | Includes bibliographical references and index. |
| Access restriction | Available only to authorized users. |
| Technical details | Mode of access: World Wide Web |
| Genre/form | Electronic books. |
| LCCN | 2024006436 |
| ISBN | 9780197675229 (hardback) |
| ISBN | (epub) |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |